Praxis Precision Medicines, Inc.
PRAX
$37.20
$0.792.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2,371.19% | -15.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2,371.19% | -15.41% | |||
| Cost of Revenue | 34.40% | 53.64% | |||
| Gross Profit | -17.43% | -54.55% | |||
| SG&A Expenses | -0.82% | 44.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.00% | 50.98% | |||
| Operating Income | -12.53% | -51.61% | |||
| Income Before Tax | -13.04% | -58.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -13.04% | -58.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.04% | -58.86% | |||
| EBIT | -12.53% | -51.61% | |||
| EBITDA | -12.63% | -51.80% | |||
| EPS Basic | -6.84% | -58.35% | |||
| Normalized Basic EPS | -9.37% | -58.36% | |||
| EPS Diluted | -6.84% | -58.35% | |||
| Normalized Diluted EPS | -9.37% | -58.36% | |||
| Average Basic Shares Outstanding | 5.80% | 0.32% | |||
| Average Diluted Shares Outstanding | 5.80% | 0.32% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||